BioNTech/Comirnaty Covid-19 vaccines are currently available. Read more at straitstimes.com. Read more at straitstimes.com.
Buried in a technical document released by the Centers for Medicare and Medicaid Services is a convoluted paragraph that may translate into big problems for Johnson & Johnson, Merck, and other ...
Shah Capital, Novavax's second-largest shareholder, is pressing the biotech's board to pursue strategic changes, including a ...
Stocktwits on MSN
Novavax Stock Faces Retail Backlash As Shah Capital Warns Of Proxy Fight And Presses For A Sale
Shah Capital increased its stake to about 8.3% and said the gap between Novavax’s scientific potential and its commercial ...
The 2025-2026 respiratory viral season is approaching.With it comes the familiar challenge of protecting our most vulnerable ...
TAIPEI (Taiwan News) — Taiwan's Centers for Disease Control said Tuesday that 101,100 people sought emergency room treatment for flu-like illness last week, a 7.5% decrease from the previous week.
Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 4 undervalued ...
Shares of Novavax have come under renewed scrutiny as analysts update their fair value estimates in light of recent strategic shifts. The consensus analyst price target for Novavax stock has edged ...
IAVI reports its single-dose Lassa fever vaccine is safe and effective, paving way for advanced trials across West Africa.
Novavax Inc (NVAX) Q3 2025 Earnings Call Highlights: Strategic Partnerships and Financial Challenges
Novavax Inc (NVAX) focuses on innovation and partnerships amid financial hurdles, aiming for profitability by 2028.
TipRanks on MSN
Novavax’s Q3 2025 Earnings Call: Optimistic Outlook
Novavax (($NVAX)) has held its Q3 earnings call. Read on for the main highlights of the call. Novavax’s Q3 2025 Earnings Call: A Cautiously ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results